Maas, Zachary L.
Dowell, Robin D.
Funding for this research was provided by:
National Science Foundation (ABI1759949)
National Institutes of Health (GM125871)
Article History
Received: 21 March 2023
Accepted: 7 December 2023
First Online: 12 January 2024
Declarations
:
: Not applicable to this study.
: Not applicable to this study.
: Zachary Maas declares that he has no competing interests. Robin Dowell is a founder of Arpeggio Bioscience who uses nascent RNA sequencing protocols routinely.